Dana-Farber Boston Children's Cancer and Blood Disorders Center | sciencenewsnet.in

Breaking News

New York State, City and Bronx Borough Officials Celebrate the 125th Anniversary of the Bronx Zoo

Silent flight edges closer to take off, according to new research

Novel material supercharges innovation in electrostatic energy storage

A Common Pathway in the Brain That Enables Addictive Drugs to Hijack Natural Reward Processing Has Been Identified by Mount Sinai

MSU expert to attend oral arguments in SCOTUS case that could turn homelessness into a crime

New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies

Dana-Farber Chief Scientific Officer, Kevin Haigis, PhD, elected as Fellow of the American Association for the Advancement of Science

Hubble Goes Hunting for Small Main Belt Asteroids

Two U Professors Selected as AAAS Fellows

New research finds electric vehicles depreciate faster than gas cars, but the trend is changing

19 Apr, 2024

Antibody Treatment Prevents Graft Versus Host Disease, a Major Bone Marrow Transplant Complication, in Advanced Preclinical Tests

June 28, 2023 sarah JonasResearch Results

An experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease (GVHD) in the intestines, without causing broad immune suppression, in a preclinical study led by researchers from Penn Medicine and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and published today in Science Translational Medicine.

New immunotherapy target discovered for malignant brain tumors

February 15, 2021 sarah JonasResearch Results

Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted the ground-breaking cancer treatment based on harnessing the body’s immune system. The discovery, reported in the journal CELL, emerged from laboratory experiments and has no immediate implications for treating patients.